光动力疗法
放射治疗
材料科学
癌症
肝癌
癌症治疗
癌症研究
模态(人机交互)
纳米颗粒
医学物理学
肿瘤科
纳米技术
医学
放射科
内科学
化学
有机化学
人机交互
计算机科学
作者
Meitao Liu,Tianming Wang,Ke Jin,Yuanyuan Liu,Minping Zhang,Wei Chen,Xiangyu Chen
标识
DOI:10.1016/j.mtphys.2025.101767
摘要
Hepatocellular carcinoma (HCC) is an aggressive form of liver cancer. Gamma Knife is a minimally invasive treatment option for cancer, but it remains constrained by limitations such as tumor recurrence and metastatic progression. In contrast, photodynamic therapy (PDT) utilizes tumor-specific targeting while providing three clinical benefits: repeatable administration, immunomodulatory activity, and synergistic integration with systemic therapies. However, traditional PDT faces limitations in treating deep-seated tumors, such as HCC. Copper cysteamine (Cu-Cy) serves as a novel photosensitizer that can be activated directly by X-ray irradiation. Our initial studies have demonstrated that Cu-Cy can be activated by the gamma-ray emitted by the Gamma Knife, making it effective for PDT. Subsequent results showed that combining the Gamma Knife with Cu-Cy-mediated PDT can not only effectively suppress the proliferation and migration of HCC cells but also inhibit tumor growth without obvious side effects. This study substantiates the efficacy and safety of combining Gamma Knife treatment with Cu-Cy-mediated PDT for the management of HCC, while also introducing innovative theories and strategies in therapeutic approaches. Furthermore, our research offers a new perspective on the selection of excitation light sources for PDT, potentially advancing the clinical application and translational viability of Cu-Cy. • A novel modality of radiation photodynamic therapy for cancer: the combination therapy of gamma knife and Cu-Cy nanoparticle mediated photodynamic effect on liver cancer • The application of gamma ray stimulate photosensitizer mediated PDT is expected to breakthrough the limitation of traditional light source in the application of deep tumor. • Using gamma knife as clinical environment simulation is expected to promote the PDT to clinical transformation.
科研通智能强力驱动
Strongly Powered by AbleSci AI